News

A team co-led by scientists at Weill Cornell Medicine has revealed in detail how the most common primary eye cancer in adults, uveal melanoma (UM), can progress from a slow-growing, “indolent” state to a lethal metastasizing state. The discovery is a significant advance in fundamental cancer research that also suggests new strategies for treatment.

Dr. Robert S. Brown, an outstanding physician-scientist who combines clinical care with research focused on improving outcomes for patients with liver diseases, has been named chief of the Division of Gastroenterology and Hepatology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective Aug. 1.

Despite cigarette smoking being the single most preventable risk factor for both chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), two devastating diseases that make it hard to breathe, about 44 million American adults continue to smoke.

Battling a deadly blood cancer, a New Jersey woman gets a second chance — thanks to precision medicine

Tuberculosis (TB) is a wily old killer, one of the deadliest infectious diseases in history and one of the few that naturally infects only humans.

A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, suggests a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

Three recent cross-campus collaborations sparked by efforts from the Office of Academic Integration have received a total of $33 million in federal grants to solve problems at the root of human disease.

Children with infantile spasms, a rare form of epileptic seizures, should be treated with one of three recommended therapies and the use of non-standard therapies should be strongly discouraged, according to a study of their effectiveness by a Weill Cornell Medicine and NewYork-Presbyterian investigator and collaborating colleagues in the Pediatric Epilepsy Research Consortium.

Awards, honors, prizes and achievements for the month of August.

On Aug. 20, 106 students in Weill Cornell Medical College’s Class of 2025 received their short white coats during an outdoor, in-person White Coat Ceremony. 

Eating fructose appears to alter cells in the digestive tract in a way that enables it to take in more nutrients, according to a preclinical study from investigators at Weill Cornell Medicine and NewYork-Presbyterian. 

National data indicates that about a fifth of medical students, practicing physicians and medical school faculty members in the United States are Asian American. But that proportion shrinks at the top of medicine’s academic ranks, at a cost to individuals, institutions and healthcare at-large, according to new commentary by the deans of Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons. 

An immune cell subset called innate lymphoid cells (ILC3s) protects against colorectal cancer, in part by helping to maintain a healthy dialogue between the immune system and gut microbes, according to a new study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Weill Cornell Medicine has been awarded a five-year, $28.5 million Martin Delaney Collaboratory grant from the National Institutes of Health to lead a multi-institutional effort aimed at finding a cure for HIV.

The degree to which the brain’s wiring aligns with its patterns of activity can vary with sex and age, and may be genetic, suggests a study published by Weill Cornell Medicine investigators. 

Researchers at Weill Cornell Medicine have shown that they can record the high-speed motions of proteins while correlating their motion to function.

The autoimmune disease lupus may be triggered by a defective process in the development of red blood cells.

Dr. Geraldine McGinty, an esteemed clinical operations strategist, administrator and radiologist, has been appointed senior associate dean for clinical affairs at Weill Cornell Medicine

Dr. Brian DeRubertis, a leading vascular surgeon and researcher who develops innovative approaches and surgical techniques for treating conditions affecting the circulatory system, has been named chief of the Division of Vascular and Endovascular Surgery at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.